Background
Background Well-designed proWell-designed prospective studies of substance misuse in spective studies of substance misuse in first-episode psychosis can improve our first-episode psychosis can improve our understanding of the risks associated with understanding of the risks associated with comorbid substance misuse and psychosis. comorbid substance misuse and psychosis.
Aims Aims To examine the potential effects of
To examine the potential effects of substance misuse on in-patient admission substance misuse on in-patient admission and remission and relapse of positive and remission and relapse of positive symptoms in first-episode psychosis. symptoms in first-episode psychosis.
Method Method The study was a prospective
The study was a prospective 15-month follow-up investigation of103 15-month follow-up investigation of103 patients with first-episode psychosis patients with first-episode psychosis recruited from three mental health recruited from three mental health services. services.
Results

Results Substance misuse was
Substance misuse was independently associated with increased independently associated with increased risk of in-patient admission, relapse of risk of in-patient admission, relapse of positive symptoms and shorter time to positive symptoms and shorter time to relapse of positive symptoms after relapse of positive symptoms after controlling for potential confounding controlling for potential confounding factors. Substance misuse was not factors. Substance misuse was not associated with remission or time to associated with remission or time to remission of positive symptoms.Heavy remission of positive symptoms.Heavy substance misuse was associated with substance misuse was associated with increased risk of in-patient admission, increased risk of in-patient admission, relapse and shorter time to relapse. relapse and shorter time to relapse.
Conclusions Conclusions Substance misuse is an
Substance misuse is an independent risk factor for a problematic independent risk factor for a problematic recovery from first-episode psychosis. recovery from first-episode psychosis.
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Research on substance misuse in psychotic Research on substance misuse in psychotic disorders has been hampered by methoddisorders has been hampered by methodological limitations including selection bias, ological limitations including selection bias, lack of diagnostic rigour, failure to control lack of diagnostic rigour, failure to control for potential confounding variables and a for potential confounding variables and a lack of prospective follow-up studies (Blanlack of prospective follow-up studies (Blanchard chard et al et al, 2000; Murray , 2000; Murray et al et al, 2003) . , 2003) . Prospective studies of first-episode psychoProspective studies of first-episode psychosis can address these issues and improve sis can address these issues and improve our understanding of the risks associated our understanding of the risks associated with comorbid substance misuse and psywith comorbid substance misuse and psychosis. A small number of prospective chosis. A small number of prospective studies have reported that substance misuse studies have reported that substance misuse is associated with a problematic recovery is associated with a problematic recovery from recent-onset psychosis (Linszen from recent-onset psychosis (Linszen et al et al, , 1994; Strakowski 1994; Strakowski et al et al, 1998; Sorbara , 1998; Sorbara et et al al, 2003) . Consistent with the findings of , 2003) . Consistent with the findings of these studies, our hypotheses for the current these studies, our hypotheses for the current study were that substance misuse in firststudy were that substance misuse in firstepisode psychosis would be associated with episode psychosis would be associated with increased risk of in-patient admission, a increased risk of in-patient admission, a longer time to remission of positive symplonger time to remission of positive symptoms, and earlier and increased risk of toms, and earlier and increased risk of relapse of positive symptoms. relapse of positive symptoms.
METHOD METHOD Participants Participants
Consecutive in-patient and out-patient Consecutive in-patient and out-patient admissions of individuals with first-episode admissions of individuals with first-episode psychosis were screened for the study psychosis were screened for the study between January and December 1997 at between January and December 1997 at the Central East Area Mental Health Serthe Central East Area Mental Health Service (CEAMHS) and the Northern Area vice (CEAMHS) and the Northern Area Mental Health Service (NAMHS), and Mental Health Service (NAMHS), and between March and July 2001 at the Early between March and July 2001 at the Early Psychosis Prevention and Intervention CenPsychosis Prevention and Intervention Centre (EPPIC) in Melbourne, Australia. The tre (EPPIC) in Melbourne, Australia. The CEAMHS and the NAMHS are generic CEAMHS and the NAMHS are generic mental health services for adults with mental health services for adults with serious mental illnesses and EPPIC is a serious mental illnesses and EPPIC is a specialist mental health service for youth specialist mental health service for youth with first-episode psychosis. The services with first-episode psychosis. The services provide comprehensive care within defined provide comprehensive care within defined catchment areas and are funded by the state catchment areas and are funded by the state government. The inclusion criteria for the government. The inclusion criteria for the study were age 15-30 years, fluency in study were age 15-30 years, fluency in English, ability to give informed consent, English, ability to give informed consent, and clear evidence of a functional psychotic and clear evidence of a functional psychotic disorder. The exclusion criteria were disorder. The exclusion criteria were organic aetiology, learning disability, hisorganic aetiology, learning disability, history of brain damage or epilepsy, and more tory of brain damage or epilepsy, and more than 6 months of prior treatment for a psythan 6 months of prior treatment for a psychotic disorder. The aims of the study were chotic disorder. The aims of the study were fully explained to the participants, who fully explained to the participants, who provided written informed consent. The reprovided written informed consent. The research and ethics committees of the Northsearch and ethics committees of the NorthWestern Mental Health Program approved Western Mental Health Program approved the study. In total 126 patients (EPPIC the study. In total 126 patients (EPPIC n n¼71; CEAMHS 71; CEAMHS n n¼32; NAMHS 32; NAMHS n n¼23) 23) were recruited to the study. Twenty-three were recruited to the study. Twenty-three patients had missing data regarding the patients had missing data regarding the presence of any substance misuse during presence of any substance misuse during follow-up owing to their not being contactfollow-up owing to their not being contactable at the 9-month or 15-month time point able at the 9-month or 15-month time point and were excluded from further analyses, and were excluded from further analyses, leaving a sample of 103 patients (EPPIC leaving a sample of 103 patients (EPPIC n n¼59, CEAMHS 59, CEAMHS n n¼25, NAMHS 25, NAMHS n n¼19). 19). For patients who were eligible for the study For patients who were eligible for the study at EPPIC ( at EPPIC (n n¼95), no significant difference 95), no significant difference was found between patients included was found between patients included ( (n n¼59) and not included ( 59) and not included (n n¼36) in the 36) in the current analyses on demographic variables, current analyses on demographic variables, psychotic disorder diagnosis or duration of psychotic disorder diagnosis or duration of untreated psychosis. untreated psychosis.
Measures and procedure Measures and procedure
A baseline assessment was completed at A baseline assessment was completed at entry to treatment, and follow-up assessentry to treatment, and follow-up assessments were undertaken 3 months, 9 months ments were undertaken 3 months, 9 months and 15 months following the initial assessand 15 months following the initial assessment. An updated version of the Royal Park ment. An updated version of the Royal Park Multidiagnostic Instrument for Psychoses Multidiagnostic Instrument for Psychoses (RPMIP; McGorry (RPMIP; McGorry et al et al, 1990 McGorry et al et al, ) was used , 1990 ) was used to diagnose DSM-IV (American Psychiatric to diagnose DSM-IV (American Psychiatric Association, 1994) psychotic disorders Association, 1994) psychotic disorders based on assessment at baseline and based on assessment at baseline and 3-month follow-up. Diagnoses were 3-month follow-up. Diagnoses were subsequently categorised as schizophreniasubsequently categorised as schizophreniaspectrum psychosis (schizophrenia, schizospectrum psychosis (schizophrenia, schizophreniform, schizoaffective or delusional) phreniform, schizoaffective or delusional) or other psychosis (bipolar, major depresor other psychosis (bipolar, major depression, not otherwise specified, substancesion, not otherwise specified, substanceinduced or brief). The RPMIP was also used induced or brief). The RPMIP was also used to estimate the duration of untreated psyto estimate the duration of untreated psychosis in days, defined as the time from chosis in days, defined as the time from onset of psychotic symptoms to treatment onset of psychotic symptoms to treatment entry. The Chemical Use, Abuse and entry. The Chemical Use, Abuse and Dependence Scale (CUAD; McGovern & Dependence Scale (CUAD; ) was used to diagnose Morrison, 1992) was used to diagnose DSM-III-R (American Psychiatric Associa-DSM-III-R (American Psychiatric Association, 1987) substance misuse (criteria met tion, 1987) substance misuse (criteria met for abuse or dependence) during the for abuse or dependence) during the 15-month follow-up period. Substance mis-15-month follow-up period. Substance misuse was assessed at the 9-month time point use was assessed at the 9-month time point (for the interval between baseline and 9 (for the interval between baseline and 9 months) and the 15-month time point (for months) and the 15-month time point (for the interval between 9 months and 15 the interval between 9 months and 15 months). Substances assessed for included months). Substances assessed for included alcohol, amphetamine, benzodiazepine, alcohol, amphetamine, benzodiazepine, cannabis, cocaine, hallucinogen, inhalant, cannabis, cocaine, hallucinogen, inhalant, opioid and phencyclidine. Diagnoses of opioid and phencyclidine. Diagnoses of substance misuse were based on the 17 substance misuse were based on the 17 items rated 'true' or 'false' for each items rated 'true' or 'false' for each substance. Each item corresponds to a crisubstance. Each item corresponds to a criterion of DSM-III-R substance abuse or terion of DSM-III-R substance abuse or dependence. Individual substance use severdependence. Individual substance use severity scores are based on weighted scores ity scores are based on weighted scores from 1 to 4 for the 17 items rated 'true' from 1 to 4 for the 17 items rated 'true' for each substance. The sum of individual for each substance. The sum of individual substance use severity scores provides a substance use severity scores provides a total substance use severity score. The total substance use severity score. The higher total substance use severity score at higher total substance use severity score at the 9-or 15-month time point was used the 9-or 15-month time point was used to calculate the total substance use severity to calculate the total substance use severity score during the follow-up period. As in the score during the follow-up period. As in the study by Kavanagh study by Kavanagh et al et al (2004 Kavanagh et al et al ( ), any misuse (2004 , any misuse of substances other than alcohol or cannaof substances other than alcohol or cannabis was defined as 'other substance misuse' bis was defined as 'other substance misuse' and the presence of at least two of alcohol, and the presence of at least two of alcohol, cannabis or other substance misuse was cannabis or other substance misuse was defined as 'poly-substance misuse'. Patients defined as 'poly-substance misuse'. Patients with substance misuse were grouped acwith substance misuse were grouped according to the pattern of substance misuse cording to the pattern of substance misuse as follows: cannabis misuse; other but not as follows: cannabis misuse; other but not cannabis misuse; or alcohol misuse only. cannabis misuse; or alcohol misuse only. Substance misuse was categorised as mild Substance misuse was categorised as mild or heavy based on a median split of CUAD or heavy based on a median split of CUAD total substance use severity scores. total substance use severity scores.
Remission and relapse of positive psyRemission and relapse of positive psychotic symptoms were the primary clinical chotic symptoms were the primary clinical outcomes. The Brief Psychiatric Rating outcomes. The Brief Psychiatric Rating Scale (BPRS; Lukoff Scale (BPRS; Lukoff et al et al, 1986 ) was used , 1986) was used to rate remission and relapse of positive to rate remission and relapse of positive symptoms according to the following crisymptoms according to the following criteria: remission was defined as a score teria: remission was defined as a score of 3 (mild) or less on all of the BPRS of 3 (mild) or less on all of the BPRS Psychotic sub-scale items (hallucinations, Psychotic sub-scale items (hallucinations, conceptual disorganisation, unusual thought conceptual disorganisation, unusual thought content and suspiciousness) for at least 2 content and suspiciousness) for at least 2 weeks; relapse was defined as a score of 4 weeks; relapse was defined as a score of 4 (moderate) or more on any of the BPRS (moderate) or more on any of the BPRS Psychotic sub-scale items for at least 1 week Psychotic sub-scale items for at least 1 week after achieving remission. Assessment for after achieving remission. Assessment for remission and relapse was undertaken at remission and relapse was undertaken at all three follow-up assessments and, if all three follow-up assessments and, if relevant, estimates of the date of onset relevant, estimates of the date of onset and offset of remission or relapse were and offset of remission or relapse were derived by asking patients to recall the derived by asking patients to recall the date when criteria were first met, using date when criteria were first met, using prompts of significant calendar dates if prompts of significant calendar dates if necessary. Medication compliance was necessary. Medication compliance was rated on a four-point scale: 1 for 0-24% rated on a four-point scale: 1 for 0-24% compliance (no or irregular compliance); 2 compliance (no or irregular compliance); 2 for 25-49% compliance (rather irregular for 25-49% compliance (rather irregular compliance); 3 for 50-74% compliance compliance); 3 for 50-74% compliance (rather regular compliance); 4 for 75-(rather regular compliance); 4 for 75-100% compliance (regular compliance). 100% compliance (regular compliance). Ratings were subsequently recoded to Ratings were subsequently recoded to denote compliance (a score of 4) or denote compliance (a score of 4) or non-compliance (a score of 3 or less). Medinon-compliance (a score of 3 or less). Medication non-compliance during follow-up cation non-compliance during follow-up was subsequently defined as the presence was subsequently defined as the presence of a score less than 4 at any time during of a score less than 4 at any time during follow-up. All diagnostic and clinical follow-up. All diagnostic and clinical assessments were based on patient interassessments were based on patient interviews supplemented by data derived from views supplemented by data derived from informants (family members and/or cliniinformants (family members and/or clinicians) and a review of medical records. cians) and a review of medical records.
In-patient admission following the In-patient admission following the initial 3-month treatment period was the initial 3-month treatment period was the primary outcome related to in-patient serprimary outcome related to in-patient service use. Most patients with first-episode vice use. Most patients with first-episode psychosis are admitted to hospital during psychosis are admitted to hospital during treatment for the initial acute phase (Power treatment for the initial acute phase (Power et al et al, 1998) . Hence, we examined whether , 1998). Hence, we examined whether substance misuse was associated with an substance misuse was associated with an increased risk of admission to hospital increased risk of admission to hospital following the initial 3-month treatment following the initial 3-month treatment period, henceforth referred to as 'in-patient period, henceforth referred to as 'in-patient admission'. Information regarding the admission'. Information regarding the number and duration of in-patient admisnumber and duration of in-patient admissions was obtained from clinical files and sions was obtained from clinical files and an electronic database. an electronic database.
Experienced raters completed clinical Experienced raters completed clinical assessments after receiving training in the assessments after receiving training in the administration of the RPMIP and BPRS administration of the RPMIP and BPRS prior to commencement of the study. Interprior to commencement of the study. Interrater agreement on the 24 BPRS items and rater agreement on the 24 BPRS items and the 4 BPRS Psychotic sub-scale items was the 4 BPRS Psychotic sub-scale items was assessed by comparing ratings made by assessed by comparing ratings made by the first author (D.W.) and a second rater the first author (D.W.) and a second rater on five cases. Agreement was defined as on five cases. Agreement was defined as the percentage of items that were rated the percentage of items that were rated within one point by both raters. A miniwithin one point by both raters. A minimum of 95% agreement was achieved mum of 95% agreement was achieved on the 24 BPRS items and the 4 BPRS on the 24 BPRS items and the 4 BPRS Psychotic sub-scale items. Psychotic sub-scale items.
Data analysis Data analysis
Univariate binary logistic regression was Univariate binary logistic regression was used to assess the effects of substance used to assess the effects of substance misuse on in-patient admission (yes/no), misuse on in-patient admission (yes/no), remission (yes/no) and relapse (yes/no). remission (yes/no) and relapse (yes/no). Kaplan-Meier survival analysis was used Kaplan-Meier survival analysis was used to compare the time to remission and time to compare the time to remission and time to relapse following remission between to relapse following remission between patient groups using the log-rank test. To patient groups using the log-rank test. To adjust for potential confounding variables, adjust for potential confounding variables, multivariate binary logistic and Cox promultivariate binary logistic and Cox proportional hazards regression models were portional hazards regression models were constructed. These models involved simulconstructed. These models involved simultaneous entry of substance misuse and the taneous entry of substance misuse and the following variables: gender, age, psychotic following variables: gender, age, psychotic disorder diagnosis (schizophrenia-spectrum disorder diagnosis (schizophrenia-spectrum or other psychosis), duration of untreated or other psychosis), duration of untreated psychosis (log-transformed owing to posipsychosis (log-transformed owing to positive skewness) and medication compliance. tive skewness) and medication compliance. All statistical tests were two-tailed and outAll statistical tests were two-tailed and outcomes treated as significant at or below the comes treated as significant at or below the 0.05 probability level. Statistical analyses 0.05 probability level. Statistical analyses were undertaken using the Statistical Packwere undertaken using the Statistical Package for the Social Sciences, version 12.0.1 age for the Social Sciences, version 12.0.1 for Windows. for Windows.
RESULTS RESULTS
Participants Participants
The mean age of the 103 patients was 21.6 The mean age of the 103 patients was 21.6 (s.d. (s.d.¼3.5) years. The patients were predo-3.5) years. The patients were predominantly male (71%) and single (90%), minantly male (71%) and single (90%), and approximately a third (34%) of the and approximately a third (34%) of the patients had completed secondary school. patients had completed secondary school. The majority of patients were diagnosed The majority of patients were diagnosed with schizophrenia-spectrum psychosis with schizophrenia-spectrum psychosis (75%) and hospitalised during the first 3 (75%) and hospitalised during the first 3 months of treatment (76%). No significant months of treatment (76%). No significant difference was found between these 103 difference was found between these 103 patients and the 23 patients excluded from patients and the 23 patients excluded from analyses because of missing substance analyses because of missing substance misuse data on demographic or clinical misuse data on demographic or clinical variables, including the rates of any or variables, including the rates of any or individual lifetime substance misuse at individual lifetime substance misuse at baseline. baseline.
Rates of substance misuse Rates of substance misuse
Overall, 53% of patients (55 out of 103) Overall, 53% of patients (55 out of 103) were given a diagnosis of substance misuse were given a diagnosis of substance misuse during follow-up; these included cannabis during follow-up; these included cannabis 42% (43 out of 103), alcohol 30% (30 42% (43 out of 103), alcohol 30% (30 out of 100) and other substance misuse out of 100) and other substance misuse 17% (17 out of 98). Thirteen of the 17 17% (17 out of 98). Thirteen of the 17 patients diagnosed with other substance patients diagnosed with other substance misuse met criteria for amphetamine and/ misuse met criteria for amphetamine and/ or hallucinogen misuse. The rate of polyor hallucinogen misuse. The rate of polysubstance misuse was 30% (31 out of substance misuse was 30% (31 out of 102). Of the patients with a diagnosis of 102). Of the patients with a diagnosis of substance misuse, 57% (31 out of 54, misssubstance misuse, 57% (31 out of 54, missing data for 1 patient) met criteria for polying data for 1 patient) met criteria for polysubstance misuse. The varying denominator substance misuse. The varying denominator for these analyses is owing to missing data for these analyses is owing to missing data on misuse of some individual substances. on misuse of some individual substances.
In-patient admission In-patient admission
The rates of in-patient admission for The rates of in-patient admission for patients with and without a diagnosis of patients with and without a diagnosis of substance misuse were 45% (25 out of substance misuse were 45% (25 out of 55) and 15% (7 out of 48) respectively 55) and 15% (7 out of 48) respectively (Table 1) . Logistic regression analyses (Table 1) . Logistic regression analyses showed that substance misuse was signifishowed that substance misuse was significantly associated with in-patient admission cantly associated with in-patient admission during follow-up and remained so after during follow-up and remained so after controlling for the effects of gender, age, controlling for the effects of gender, age, psychotic disorder diagnosis, duration of psychotic disorder diagnosis, duration of untreated psychosis and medication comuntreated psychosis and medication compliance. The mean number of in-patient pliance. The mean number of in-patient admission days was 12.0 (s. 
Remission of psychotic symptoms Remission of psychotic symptoms
For patients who achieved remission of For patients who achieved remission of positive symptoms during follow-up (98 positive symptoms during follow-up (98 out of 103), the mean duration of remission out of 103), the mean duration of remission (that is, the period from the time that remis-(that is, the period from the time that remission criteria were first met to psychotic resion criteria were first met to psychotic relapse or the end of follow-up) was 343.7 lapse or the end of follow-up) was 343.7 days (s.d. days (s.d.¼133.6, median 133.6, median¼386.0). The 386.0). The rates of remission during follow-up for parates of remission during follow-up for patients with and without a diagnosis of subtients with and without a diagnosis of substance misuse were 93% (51 out of 55) and stance misuse were 93% (51 out of 55) and 98% (47 out of 48) respectively. Univariate 98% (47 out of 48) respectively. Univariate logistic regression analyses showed that the logistic regression analyses showed that the association between substance misuse and association between substance misuse and remission was not statistically significant remission was not statistically significant (Table 1) . Multivariate analyses were not (Table 1) . Multivariate analyses were not undertaken owing to the small number of undertaken owing to the small number of patients who did not achieve remission patients who did not achieve remission ( (n n¼5). 5).
Time to remission of psychotic Time to remission of psychotic symptoms symptoms A Kaplan-Meier survival analysis showed A Kaplan-Meier survival analysis showed no significant difference between patients no significant difference between patients with substance misuse ( with substance misuse (n n¼55, 4 censored 55, 4 censored cases; median time to remission 39 days, cases; median time to remission 39 days, 95% CI 22-56) and patients without 95% CI 22-56) and patients without substance misuse ( substance misuse (n n¼48, 1 censored case; 48, 1 censored case; median time to remission 41 days, 95% median time to remission 41 days, 95% CI 31-51) on days to remission (log-rank CI 31-51) on days to remission (log-rank test, test, w w 2 2 ¼1.1, d.f. 1.1, d.f.¼1, 1, P P¼0.300). A Cox 0.300). A Cox regression analysis showed that substance regression analysis showed that substance misuse was not significantly associated with misuse was not significantly associated with time to remission (hazard ratio 0.8, 95% CI time to remission (hazard ratio 0.8, 95% CI 0.5-1.2, 0.5-1.2, P P¼0.277) after controlling for the 0.277) after controlling for the effects of gender, age, psychotic disorder effects of gender, age, psychotic disorder diagnosis, duration of untreated psychosis diagnosis, duration of untreated psychosis and medication compliance. and medication compliance.
Relapse of psychotic symptoms Relapse of psychotic symptoms
For patients who achieved remission during For patients who achieved remission during follow-up ( follow-up (n n¼98), the rates of relapse 98), the rates of relapse of positive symptoms during follow-up for of positive symptoms during follow-up for patients with and without a substance mispatients with and without a substance misuse diagnosis were 51% (26 out of 51) and use diagnosis were 51% (26 out of 51) and 17% (8 out of 47) respectively. Logistic 17% (8 out of 47) respectively. Logistic regression analyses showed that substance regression analyses showed that substance misuse was significantly associated with misuse was significantly associated with relapse and remained so after controlling relapse and remained so after controlling for the effects of gender, age, psychotic for the effects of gender, age, psychotic disorder diagnosis, duration of untreated disorder diagnosis, duration of untreated psychosis and medication compliance psychosis and medication compliance (Table 1) . When patients were grouped (Table 1) . When patients were grouped according to the pattern of substance misaccording to the pattern of substance misuse, 23 out of 40 patients with cannabis use, 23 out of 40 patients with cannabis misuse and 2 out of 4 patients with other misuse and 2 out of 4 patients with other substance misuse but not cannabis misuse substance misuse but not cannabis misuse relapsed, compared with 1 out of 7 patients relapsed, compared with 1 out of 7 patients with alcohol misuse only. with alcohol misuse only.
Time to relapse of psychotic Time to relapse of psychotic symptoms symptoms
For patients who achieved remission For patients who achieved remission ( (n n¼98), a Kaplan-Meier survival analysis 98), a Kaplan-Meier survival analysis showed that substance misuse was a signifshowed that substance misuse was a significant risk factor for time to relapse (Fig. 1) . icant risk factor for time to relapse (Fig. 1) . Patients with a diagnosis of substance Patients with a diagnosis of substance misuse ( misuse (n n¼51, 25 censored cases) had a 51, 25 censored cases) had a significantly shorter time to relapse of significantly shorter time to relapse of psychotic symptoms compared with patients psychotic symptoms compared with patients without substance misuse ( without substance misuse (n n¼47, 39 cen-47, 39 censored cases; log-rank test, sored cases; log-rank test, w w 2 2 ¼12.7 d.f. 12.7 d.f.¼1, 1, P P5 50.001). The median time to relapse 0.001). The median time to relapse for patients with substance misuse was for patients with substance misuse was 378 days (95% CI 271-485, mean 378 days (95% CI 271-485, mean¼359). 359). The median time to relapse for patients The median time to relapse for patients without substance misuse could not be without substance misuse could not be calculated because fewer than half the calculated because fewer than half the patients relapsed (mean 477 days). A Cox patients relapsed (mean 477 days). A Cox regression analysis showed that substance regression analysis showed that substance misuse remained significantly associated misuse remained significantly associated with shorter time to relapse after controlwith shorter time to relapse after controlling for the effects of gender, age, psychotic ling for the effects of gender, age, psychotic disorder diagnosis, duration of untreated disorder diagnosis, duration of untreated psychosis and medication compliance psychosis and medication compliance (hazard ratio 2.8, 95% CI 1.2-6.7, (hazard ratio 2.8, 95% CI 1.2-6.7, P P¼0.021). 0.021).
Relationship between severity of Relationship between severity of substance misuse and in-patient substance misuse and in-patient admission, relapse and time to admission, relapse and time to relapse relapse Patients whose substance misuse was catePatients whose substance misuse was categorised as heavy ( gorised as heavy (n n¼27), mild ( 27), mild (n n¼28) and 28) and none ( none (n n¼48) were compared on rates of 48) were compared on rates of in-patient admission and relapse and time in-patient admission and relapse and time to relapse. The heavy substance misuse to relapse. The heavy substance misuse group had a higher rate of in-patient admisgroup had a higher rate of in-patient admission (52%; 14 out of 27) than the mild subsion (52%; 14 out of 27) than the mild substance misuse group (39%; 11 out of 28), stance misuse group (39%; 11 out of 28), who in turn had a higher rate of in-patient who in turn had a higher rate of in-patient admission than the no substance misuse admission than the no substance misuse group (15%, 7 out of 48). A univariate logroup (15%, 7 out of 48). A univariate logistic regression analysis showed that pagistic regression analysis showed that patients with heavy or mild substance misuse tients with heavy or mild substance misuse were significantly more likely to be adwere significantly more likely to be admitted for in-patient care than patients mitted for in-patient care than patients who did not misuse substances (Table 2) . who did not misuse substances (Table 2) . Heavy but not mild substance misuse Heavy but not mild substance misuse 2 31 2 31 (7) 15 (7) 98 (47) 98 (47) 17 (8) 17 (8) NA, not applicable; OR, odds ratio. NA, not applicable; OR, odds ratio. 1. 1. Adjusted for gender, age, psychotic disorder diagnosis (schizophrenia-spectrum or other psychosis), duration of untreated psychosis (log-transformed) and medication Adjusted for gender, age, psychotic disorder diagnosis (schizophrenia-spectrum or other psychosis), duration of untreated psychosis (log-transformed) and medication non-compliance. non-compliance. 2. Missing compliance data for 1 patient; 2. Missing compliance data for 1 patient; n n¼102. 102. 3. Missing compliance data for 1 patient; 3. Missing compliance data for 1 patient; n n¼97. 97. 4. Multivariate analyses were not performed owing to the small number of patients who did not achieve remission ( 4. Multivariate analyses were not performed owing to the small number of patients who did not achieve remission (n n¼5). 5). * *P P5 50.05, ** 0.05, **P P5 50.01, *** 0.01, ***P P5 50.001. 0.001.
remained significantly associated with inremained significantly associated with inpatient admission after controlling for the patient admission after controlling for the effects of gender, age, psychotic disorder effects of gender, age, psychotic disorder diagnosis, duration of untreated psychosis, diagnosis, duration of untreated psychosis, and medication compliance (Table 2) . and medication compliance (Table 2) . Among patients whose disorder was in reAmong patients whose disorder was in remission ( mission (n n¼98), those with heavy substance 98), those with heavy substance misuse had a higher rate of relapse (64%; misuse had a higher rate of relapse (64%; 16 out of 25) than those with mild sub-16 out of 25) than those with mild substance misuse (38%; 10 out of 26), who stance misuse (38%; 10 out of 26), who in turn had a higher rate of relapse than pain turn had a higher rate of relapse than patients with no substance misuse (17%; 8 tients with no substance misuse (17%; 8 out of 47). A univariate logistic regression out of 47). A univariate logistic regression analysis showed that patients with heavy analysis showed that patients with heavy or mild substance misuse were significantly or mild substance misuse were significantly more likely to experience relapse compared more likely to experience relapse compared with patients with no substance misuse. with patients with no substance misuse. After adjusting for the effects of the covariAfter adjusting for the effects of the covariates, heavy but not mild substance misuse ates, heavy but not mild substance misuse was significantly associated with relapse was significantly associated with relapse (Table 2) . (Table 2) .
A Kaplan-Meier survival analysis A Kaplan-Meier survival analysis showed that substance use severity was a showed that substance use severity was a significant risk factor for time to relapse significant risk factor for time to relapse (Fig. 2) . Patients with heavy substance (Fig. 2) . Patients with heavy substance misuse ( misuse (n n¼25, 9 censored cases; median 25, 9 censored cases; median 327 days, 95% CI 238-416) had a shorter 327 days, 95% CI 238-416) had a shorter time to relapse of psychotic symptoms than time to relapse of psychotic symptoms than patients with mild substance misuse, a difpatients with mild substance misuse, a difference that just failed to reach statistical ference that just failed to reach statistical significance ( significance (n n¼26, 16 censored cases; log-26, 16 censored cases; logrank test, rank test, w w 2 2 ¼3.8, d.f. 3.8, d.f.¼1, 1, P P¼0.052), and a 0.052), and a significantly shorter time to relapse than significantly shorter time to relapse than patients with no substance misuse ( patients with no substance misuse (n n¼47, 47, 39 censored cases; log-rank test, 39 censored cases; log-rank test, w w
Patients with mild sub-0.001). Patients with mild substance misuse had a significantly shorter stance misuse had a significantly shorter time to relapse than patients with no subtime to relapse than patients with no substance misuse (log-rank test, stance misuse (log-rank test, w w 2 2 ¼4.3, 4.3, d.f. d.f.¼1, 1, P P¼0.038). The median time to re-0.038). The median time to relapse for patients with mild and no sublapse for patients with mild and no substance misuse could not be calculated stance misuse could not be calculated because fewer than half of these patients rebecause fewer than half of these patients relapsed. A multivariate analysis showed that lapsed. A multivariate analysis showed that heavy substance misuse (hazard ratio 4.6, heavy substance misuse (hazard ratio 4.6, 95% CI 1.7-12.5, 95% CI 1.7-12.5, P P¼0.003) but not mild 0.003) but not mild substance misuse (hazard ratio 2.0, 95% substance misuse (hazard ratio 2.0, 95% CI 0.8-5.4, CI 0.8-5.4, P P¼0.160) was significantly 0.160) was significantly associated with a shorter time to relapse associated with a shorter time to relapse compared with no substance misuse. compared with no substance misuse.
DISCUSSION DISCUSSION
The aim of the study was to examine The aim of the study was to examine the potential impact of substance misuse the potential impact of substance misuse on clinical outcome in individuals treated on clinical outcome in individuals treated for first-episode psychosis. The findings for first-episode psychosis. The findings supported the hypotheses that substance supported the hypotheses that substance misuse is associated with increased risk misuse is associated with increased risk of in-patient admission and earlier and of in-patient admission and earlier and increased risk of psychotic relapse. The hyincreased risk of psychotic relapse. The hypothesis that substance misuse is associated pothesis that substance misuse is associated with longer time to remission of positive with longer time to remission of positive symptoms was not supported. symptoms was not supported.
Strengths and limitations Strengths and limitations
A range of methodological problems have A range of methodological problems have affected the study of comorbid substance affected the study of comorbid substance misuse and psychosis. Briefly, these probmisuse and psychosis. Briefly, these problems include use of criteria to diagnose lems include use of criteria to diagnose 2 3 2 2 3 2 and without substance misuse ( and without substance misuse (n n¼47) during the 5-month follow-up. 47) during the 5-month follow-up. 15 (7) 15 (7) 17 (8) 17 (8) OR, odds ratio. OR, odds ratio. 1. Adjusted for gender, age, psychotic disorder diagnosis (schizophrenia-spectrum or other psychosis), duration of untreated psychosis (log-transformed) and medication non-1. Adjusted for gender, age, psychotic disorder diagnosis (schizophrenia-spectrum or other psychosis), duration of untreated psychosis (log-transformed) and medication noncompliance. compliance. 2. Missing compliance data for 1 patient; 2. Missing compliance data for 1 patient; n n¼102. 102. 3. Missing compliance data for 1 patient; 3. Missing compliance data for 1 patient; n n¼97. 97. 4. Reference category. 4. Reference category. * *P P5 50.05, ** 0.05, **P P5 50.01, *** 0.01, ***P P5 50.001. 0.001.
substance misuse other than abuse or substance misuse other than abuse or dependence; limited assessment of a single dependence; limited assessment of a single substance or class of substances rather than substance or class of substances rather than a broader assessment that encompasses a broader assessment that encompasses multiple substance use; analysis of the multiple substance use; analysis of the effects of past or lifetime substance misuse effects of past or lifetime substance misuse rather than current substance misuse; rather than current substance misuse; diagnosis of substance misuse based on diagnosis of substance misuse based on unreliable methods such as chart review unreliable methods such as chart review rather than the use of structured interrather than the use of structured interviews views combined with data collection combined with data collection from multiple sources; failure to control from multiple sources; failure to control for medication non-compliance and other for medication non-compliance and other potential confounders; recruitment from potential confounders; recruitment from hospital rather than in-patient and hospital rather than in-patient and community-based settings; and a lack of community-based settings; and a lack of prospective studies (Blanchard prospective studies (Blanchard et al et al, 2000; , 2000; Murray Murray et al et al, 2003) . Our study sought to , 2003). Our study sought to address these problems in a sample of address these problems in a sample of young patients treated at three psychiatric young patients treated at three psychiatric services for a broad range of first-episode services for a broad range of first-episode psychotic disorders. psychotic disorders.
This study has several limitations. This study has several limitations. First, the relatively small sample size First, the relatively small sample size might have limited the power to detect might have limited the power to detect important associations of clinical signifiimportant associations of clinical significance. Second, substance misuse might cance. Second, substance misuse might have been underreported, given that the have been underreported, given that the diagnosis of substance misuse relied upon diagnosis of substance misuse relied upon patient interviews supplemented by colpatient interviews supplemented by collateral information and did not include lateral information and did not include biomedical screening tests. However, the biomedical screening tests. However, the relatively high rate of substance misuse relatively high rate of substance misuse found in the study tends to discount this found in the study tends to discount this possibility and is consistent with anecdotal possibility and is consistent with anecdotal reports from research interviewers that reports from research interviewers that most patients were willing to discuss most patients were willing to discuss substance-related problems. Further, urine substance-related problems. Further, urine drug screens can only detect substance use drug screens can only detect substance use within a limited period and cannot provide within a limited period and cannot provide information about the functional impact of information about the functional impact of substance misuse necessary to make a diagsubstance misuse necessary to make a diagnosis. Third, analysis of the independent nosis. Third, analysis of the independent effects of different types of substance miseffects of different types of substance misuse on outcome was not possible, given that use on outcome was not possible, given that more than half of the patients with a diagmore than half of the patients with a diagnosis of substance misuse met criteria for nosis of substance misuse met criteria for poly-substance misuse. The finding that poly-substance misuse. The finding that 87% of patients with substance misuse 87% of patients with substance misuse met criteria for cannabis and/or other met criteria for cannabis and/or other substance misuse tends to implicate these substance misuse tends to implicate these substances in the observed adverse effects substances in the observed adverse effects of substance misuse. Descriptive analyses of substance misuse. Descriptive analyses suggested that patients with alcohol missuggested that patients with alcohol misuse only were less likely to experience use only were less likely to experience in-patient admission or relapse compared in-patient admission or relapse compared with patients reporting cannabis or other with patients reporting cannabis or other substance misuse. These findings are substance misuse. These findings are consistent with evidence for a stronger consistent with evidence for a stronger association between psychotic exacerbaassociation between psychotic exacerbations and cannabis or stimulant misuse tions and cannabis or stimulant misuse compared with alcohol misuse (Dixon, compared with alcohol misuse (Dixon, 1999) . Fourth, the operational definition 1999). Fourth, the operational definition of remission (minimal positive symptoms of remission (minimal positive symptoms for at least 2 weeks) may be criticised for for at least 2 weeks) may be criticised for the relatively low threshold for remission the relatively low threshold for remission criteria to be met (Andreasen criteria to be met (Andreasen et al et al, 2005) . , 2005). However, 94 of the 98 patients in remission However, 94 of the 98 patients in remission maintained their initial remission of posimaintained their initial remission of positive symptoms for at least 8 consecutive tive symptoms for at least 8 consecutive weeks, which is similar to criteria used in weeks, which is similar to criteria used in other studies of first-episode psychosis other studies of first-episode psychosis (e.g. Lieberman (e.g. Lieberman et al et al, 1993; Amminger , 1993; Amminger et et al al, 1997) .
, 1997).
Comparison of current findings
Comparison of current findings with other research with other research
Several (but not all) prospective studies Several (but not all) prospective studies have reported associations between subhave reported associations between substance stance misuse and worse outcome in misuse and worse outcome in first-episode or recent-onset psychosis. Sorfirst-episode or recent-onset psychosis. Sorbara bara et al et al (2003) found that drug misuse (2003) found that drug misuse but not alcohol misuse in first-episode psybut not alcohol misuse in first-episode psychosis was associated with an increased risk chosis was associated with an increased risk of in-patient admission. It is worth noting, of in-patient admission. It is worth noting, however, that 5 of the 13 alcohol misusers however, that 5 of the 13 alcohol misusers were also diagnosed with drug misuse in were also diagnosed with drug misuse in this study. Linszen this study. Linszen et al et al (1994) found that (1994) found that cannabis misuse in recent-onset psychosis cannabis misuse in recent-onset psychosis was associated with earlier relapse and was associated with earlier relapse and an increased risk of relapse of positive an increased risk of relapse of positive symptoms. Despite differences in the definisymptoms. Despite differences in the definitions of substance misuse and relapse, our tions of substance misuse and relapse, our study and Linszen study and Linszen et al et al (1994 Linszen et al et al ( ) found (1994 found similar rates of relapse in misusing (51% similar rates of relapse in misusing (51% and 42% respectively) and non-misusing and 42% respectively) and non-misusing patients (17% in both studies). Sevy patients (17% in both studies). Sevy et al et al (2001) did not find a link between sub-(2001) did not find a link between substance misuse in first-episode psychosis stance misuse in first-episode psychosis and earlier relapse or an increased risk of and earlier relapse or an increased risk of relapse; this negative finding might have relapse; this negative finding might have been owing to the analysis of effects of been owing to the analysis of effects of substance misuse diagnosed at initial presubstance misuse diagnosed at initial presentation rather than during the follow-up sentation rather than during the follow-up treatment period. treatment period.
In contrast to our findings, Strakowski In contrast to our findings, Strakowski et al et al (1998) reported that substance misuse (1998) reported that substance misuse in first-episode affective psychosis was in first-episode affective psychosis was associated with a longer time to symptoassociated with a longer time to symptomatic remission. Differences in sample matic remission. Differences in sample characteristics and methodology between characteristics and methodology between the two studies may help to explain the disthe two studies may help to explain the discrepant findings. For example, Strakowski crepant findings. For example, Strakowski et al et al (1998) recruited patients with bipolar (1998) recruited patients with bipolar or major depressive disorder with psychosis or major depressive disorder with psychosis rather than a broad range of psychotic disrather than a broad range of psychotic disorders, and operationally defined remission orders, and operationally defined remission in terms of positive, negative and affective in terms of positive, negative and affective symptoms rather than positive symptoms symptoms rather than positive symptoms alone. It is also feasible that the lack of alone. It is also feasible that the lack of association between substance misuse and association between substance misuse and remission of positive symptoms in our remission of positive symptoms in our study might have resulted from variation study might have resulted from variation in the severity of substance use following in the severity of substance use following entry to treatment. That is, patients might entry to treatment. That is, patients might have reduced or stopped their substance have reduced or stopped their substance use immediately following entry to treatuse immediately following entry to treatment in response to the onset of acute ment in response to the onset of acute psychosis and/or subsequent treatment psychosis and/or subsequent treatment 2 3 3 2 3 3 Survival curves for time to psychotic relapse for patients in remission with no substance misuse ( (n n¼47), mild substance misuse ( 47), mild substance misuse (n n¼26) and heavy substance misuse ( 26) and heavy substance misuse (n n¼25) during the 15-month follow-up. 25) during the 15-month follow-up.
